COMB157G23101: A Single-arm, Prospective, Multicentre, Open-label Study to Evaluate Ofatumumab Treatment Effectiveness and Patient Reported Outcomes in Patients With Relapsing Multiple Sclerosis Transitioning From Dimethyl Fumarate or Fingolimod Therapy

April 07, 2021
https://clinicaltrials.gov/ct2/show/NCT04353492
Multiple Sclerosis
Principal Investigator: Mirela Cerghet, MD
Multiple Sclerosis, Sclerosis, Pathologic Processes, Demyelinating Autoimmune Diseases, CNS, Autoimmune Diseases of the Nervous System, Nervous System Diseases
Accepting Participants
313-916-1482